Pravastatin Sodium Tablets Recalled Due to Manufacturing Deviations
Glenmark Pharmaceuticals Inc. is recalling Pravastatin Sodium 20mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lot numbers distributed across the U.S.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations. No illnesses, injuries, or actual harm from the manufacturing deviation is reported in the source text. CGMP violations represent potential compliance and process issues rather than confirmed product defects or contamination.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Pravastatin Sodium Tablets 20mg in 500-count bottles (NDC# 68462-196-05) and 90-count bottles (NDC# 68462-196-90) distributed nationwide. The recall was initiated on March 13, 2025.
The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturing process. The affected lot numbers are 17230810, 17230811, 17232501, and 17232502, with expiration dates of March 2026 and November 2026.
This is a voluntary, firm-initiated recall that was notified to the FDA by letter. Patients taking affected tablets should consult their healthcare provider or pharmacist about alternative supplies. Consumers who have purchased affected lots should stop taking the product and contact their pharmacy or Glenmark for guidance on obtaining replacement medication.
The recalled product
- Product
- PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Tablet
- Hazard
- cGMP-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # 17230810
- exp. date Mar-26 17230811
- exp. date Mar-26 17230810
- exp. date Mar-26 17232501
- exp. date Nov-26 17232502
- exp. date Nov-26
UPCs (2)
- 0368462195901
- 0368462198902
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PRAVASTATIN SODIUM
- ModeratePravastatin Sodium 20mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- ModerateGlenmark Pharmaceuticals Recalls Pravastatin Sodium Tablets 80mg
FDA (Drugs) · 2025-04-16
- ModeratePravastatin Sodium Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-16
- HighPravastatin Sodium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-07-24
- HighFDA Recalls Pravastatin Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2023-03-08
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22